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CLINICAL CASE

LIFESTYLE MEDICINE APPLIED TO LATE COMPLICATIONS
OF DIABETES MELLITUS.
MEDICINA DE ESTILOS DE VIDA APLICADO A COMPLICACIONES TARDÍAS DE LA DIABETES MELLITUS.
REPORTE DE CASO
Edwin Castillo Velarde 1,2,a

ABSTRACT
Introduction: Diabetes mellitus is the main cause of progression of chronic kidney disease and dialysis. The
therapeutic intervention considers an HbA1C level that avoids adverse eﬀects associated with hypoglycemic
therapy, as occurs in patients with chronic kidney disease, despite not reaching normoglycemia. Clinical

CLINICAL CASE

Case: The present case describes an intervention based on Lifestyle Medicine in a patient with diabetic
nephropathy and chronic kidney disease, whose biomarkers showed improvement in kidney damage due to
reduction of proteinuria or reduction of HbA1C, LDL and triglycerides in its metabolic control. Conclusion:
The intervention with lifestyle medicine requires a multidisciplinary approach and the time of intervention
does not discriminate a degree of chronic kidney disease that limits its intervention
Keywords: Lifestyle Medicine, diabetic nephropathy: (Source: Mesh – NLM)

RESUMEN
Introducción: La diabetes mellitus es la principal causa de progresión de la enfermedad renal crónica y
diálisis. La intervención terapéutica considera un nivel de HbA1C que evite efectos adversos asociados a la
terapia hipoglicemiante como ocurre en el paciente con enfermedad renal crónica, pese a no se alcance la
normoglicemia. Caso Clínico: El presente caso describe una intervención basada en Medicina de Estilos de
Vida en un paciente con nefropatía diabética y enfermedad renal crónica, cuyos biomarcadores mostraron
mejoría en daño renal por reducción de la proteinuria o reducción de HbA1C, LDL y triglicéridos en su control
metabólico. Conclusión: La intervención con medicina de estilos de vida requiere un enfoque
multidisciplinario y su momento de intervención no discrimina un grado de enfermedad renal crónica que
limite su intervención.
Palabras clave: Medicina de estilos de vida, nefropatía diabética. (Fuente: Decs – BIREME)
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INTRODUCTION

CLINICAL CASE

In diabetic nephropathy and other chronic or advanced
microvascular complications due to diabetes mellitus,
the use of intensive hypoglycemic therapy has been
questioned, considering that, at this level of disease, the
incidence of adverse eﬀec ts associated with
hypoglycemic therapy increases. Intensive therapy
(HbA1C< 7%) has demonstrated its long-term bene t in
the incidence of microvascular damage due to diabetes
mellitus according to a prospective study of more than
10 years (UKPDS) (1) . The Asociación Americana de
Diabetes (ADA) in its 2020 guideline considers a HbA1C
level <7% as a therapeutic objective for the general
population, despite the fact that normal values in
physiology uctuate from 4.5 to 5%.
Only in those patients without risk of hypoglycemia or
adverse eﬀec ts from therapy, the guidelines
recommend an HbA1C level <6.5%. Patients with
chronic kidney disease are comorbid and at risk of
hypoglycemia, therefore, although diabetes is the
leading cause of dialysis in the world, the therapeutic
target in diabetic nephropathy according to the ADA is
only H bA1C <7%. Even if there is advanced
microvascular damage the guideline sets a less
stringent target of HbA1C <8%(2) . Therefore, if evidencebased management focused on HbA1C is decided, it is
not possible to guarantee normoglycemia. Evidencebased medicine, as it should be, should be patientcentered, with the therapeutic objective being
metabolic control in its totality, its core being
nutritional intervention and, in addition to this, all
aspects of lifestyles. The present case represents a
patient with chronic manifestations of diabetes mellitus
in whom it is possible to evaluate the eﬀect of
intervention with lifestyle medicine.

CLINICAL CASE
A 33-year-old male patient with a history of type 2
diabetes mellitus 12 years ago with late complications.
History of retinopathy with retinal detachment. He

receives treatment with insulin therapy 35 U/d,
metformin, atorvastatin. He was referred to nephrology
for foamy urine. On examination, normotensive, BMI 32,
trophic changes in lower limbs associated with signs of
peripheral arterial insuﬃciency and no edema.
His occupation was cable installation technician, during
his working day he ate outside the home, and at home,
he ate what they had cooked for the whole family. He
had no dietary restrictions of any kind and his diet
included fast-absorbing carbohydrates such as re ned
ours like bread at breakfast, soft drinks and polymers
in his meals such as rice, potato. He also had no
restriction for type of vegetables or fruits. The patient
had regular control by endocrinology and the insulin
therapy and metformin regimen was without variation
based on the HbA1C controls.
He had also had a nutritional consultation. At the rst
nephrology visit, the patient was informed of the
degree of chronic kidney disease, the risk of progression
associated with his diabetes mellitus, the
recommendations on potential nephrotoxic agents to
avoid and the use of angiotensin 2 receptor antagonists
was pharmacologically prescribed because of the
diabetic nephropathy. But it was also decided to make
an intervention based on lifestyles centered on
nutrition. Physical activity was suggested, but the
patient reported a poor adherent disposition.
Considering the time schedule of the outpatient clinic
of 15 minutes, it was decided to prioritize dietary
recommendations. On the other hand, the patient did
not have sleep problems, whose period was 7 hours, nor
did he have mood problems. Table 1 shows the followup analyses for the duration of the nutritional
intervention in six months, considering that the deferral
of appointments in the health system uctuates from 6
to 8 weeks. There was adequate adherence during the
intervention.

Table 1. Follow-up analysis during the intervention with MEV (Lifestyle Medicine).
Visit 1

Visit 2

Visit 3

Visit 4

Proteinuria (mg/24 hours)

2341

1813

1600

495

Creatinine (mg/dl)

1.39

1.33

1.44

1.38

HbA1c (%)

7.1

-

-

6.8

Triglycerides (mg/dl)

201

-

-

118

Cholesterol LDL (mg/dl)

105

-

-

88
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The intention is motivational because of the clear
conviction of the reversible capacity of lifestyle change.
In the second visit, the changes made by the patient
were positively reinforced and he does not consume
simple absorption carbohydrates. We explore what may
limit the patient's dietary adherence. The patient's
direction is encouraged, which implies recognizing the
need for culinary knowledge and the projection that
food has in the family and social aspect. The patient
modulated his lunch, began to take his food with him
on occasion and to modify the dietary pattern for
dinner.
In the third visit the positive reinforcement continued.
At this time we explored what anchors his behavioral
patterns of eating habits that limit adherence.
Knowledge and preparation of what is eaten continues
to be promoted and information for this purpose
continues to be provided. The distribution of
macronutrients reduced carbohydrates, increased the
fat component and maintained protein in proportion.
Although the consumption of animal proteins was not
promoted due to diabetic nephropathy, the whole
intervention was focused on modulating
carbohydrates with greater consumption of raw
vegetables.

At the last visit, the control analyses are reviewed, which
show improvement in terms of glycemic, lipemic and
renal damage control due to reduction of proteinuria.
Although the improvement of the analyses contributes
to the patient's motivation, maintaining adherence
faces a possible relapse of the behavioral habit or
relapse of the type of diet that "integrates" him in his
family and social aspect. Therefore, the intervention
must be continuous, requiring an integrated team in
lifestyle medicine. During the intervention the patient
did not reduce the level of insulin therapy, however, he
did not repor t episodes of hypoglycemia.
Subsequently, the patient discontinued follow-up due
to work problems.

DISCUSSION
Lifestyle intervention has shown that it is possible to
induce changes in the patient's metabolic control
re ected in a reduction of hypoglycemic medication. In
2007, the randomized study AHEAD (Action for Health
in Diabetes) (3) , included 5145 patients with type 2
diabetes and performed a dietary intervention (with
caloric restriction, 30% fat, up to 10% saturated, 15%
protein), physical activity based on METS (metabolic
equivalent of at least 4) and group sessions with
behavioral psychologists. Follow-up was 1 year and the
percentage reduction in hypoglycemic use was 7.8%
compared to the control group. However, the design of
this study did not consider an implemented protocol for
hypoglycemic medication reduction. In 2010, the
randomized IDES study (The Italian Diabetes and
Exercise Study) (4) enrolled 606 patients with type 2
diabetes mellitus and, in addition to caloric restriction,
performed a supervised aerobic and resistance exercise
inter vention with a time according to the
recommendation of the American College of Sports
Medicine (5) of 150 minutes per week, achieving a
discontinuation of insulin therapy in 13.5% of patients
as opposed to 0% of the control group with standard
treatment. Other studies have reported a reduction in
the use of hypoglycemic medication in up to 73.5% of
the lifestyle intervention group (6) . Most of these studies,
although randomized, have not been designed with
blinded participants (given the nature of the
intervention), so the report of the diet is referred by the
patient, the follow-up is only 12 months and in the
exclusion criteria, they consider patients with late
complications of diabetes such as retinopathy,
macroalbuminuria and advanced chronic kidney
disease.

CLINICAL CASE

The intervention consisted of transmitting to the
patient at the rst visit, medical information about the
eﬀect of postprandial glucose elevations that are not
necessarily assessed in fasting glycemia, the type of
carbohydrate, the eﬀect of renal toxicity that poorly
controlled glycemia has on the inexorable progression
of chronic kidney disease requiring dialysis if a lifestyle
intervention is not performed, that an HbA1c value
above the normal range (4. 5-5%) is associated with
poorly controlled glycemia and equally, chronic
microvascular damage and that pharmacological
intervention to reduce to a HbA1c level below 7% is
associated with hypoglycemia as an adverse eﬀect to
the insulin regimen or hypoglycemic therapy. This
information is transmitted in an empathic way, in terms
understandable to the patient and integrates a
"preaching of what is done", in that a dietary discourse
should be consistent with a medical practice of not
consuming sodas, fried foods, junk food (due to the
excess of salt, sugar, oxidation products) and reinforce
the bene t of consuming vegetables and fruits (due to
ber, trace elements, minerals and vitamins).
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CLINICAL CASE

In 2009, Buse, et al (7), published the criteria for partial
and complete remission of diabetes. Partial remission, if
HbA1C is <6.5% and fasting glycemia between 100 and
125 mg/dl; complete remission, if HbA1C is <6% and
fasting glycemia <100 mg/dl, both without use of
hypoglycemic medication. This criterion was
considered in the design of the DIRECT study (8,9), whose
lifestyle intervention for weight reduction had diabetes
remission as its primary objective.
This study showed a 36% remission of diabetes mellitus
after two years of follow-up, being up to 70% in the
group that had maintained a weight loss of more than
15 kg. The design of this study contemplated a rst
phase of dietary replacement in the rst 12 weeks with a
liquid formula with a caloric restriction of 850 Kcal/d, a
second phase of 6 weeks of dietary reintroduction, and
nally a weight loss maintenance phase (50%
carbohydrate, 35% fat and 15% protein regimen).
Complementary information was provided to promote
physical activity, face-to-face or telephone follow-up
with the nutritionist or nursing staﬀ, and diﬀerent
protocols were developed for the reduction or
reintroduction of hypoglycemic or antihypertensive
medication.
The impact of lifestyle intervention in diabetes has been
demonstrated and in our clinical case we report the
response in a patient with stage 3 chronic kidney
disease (GFR 56 by MDRD4-IDMS), however, the lack of
integration of a multidisciplinary team and the
limitations of the health system itself, ultimately
intervene in the lack of adherence of a patient. In the
DIRECT study, the importance of these aspects to
achieve the maintenance of the clinical objective is
denoted, since those patients who maintained
remission of diabetes at 12 and 24 months had an
average weight loss of 10.4 kg, while those who had
remission at 12 months but relapsed at 24 months had a
weight loss of 3.7 kg.

Authorship contributions: Draft manuscript, literature
review and nal version.
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In patients with stage 3 chronic kidney disease, other
intervention protocols have been designed to oﬀer a
dietary replacement, but based on the patient's daily
diet, excluding sugars and starches. It also requires a
multidisciplinary team and behavioral interventions(10).
In 2020, the ADA has considered diets such as
Mediterranean, low or very low carbohydrate,
vegetarian and plant-based diets as healthy eating
patterns in diabetes (2). Likewise, a complete lifestyle
intervention requires management of other areas such
as sleep quality, stress management, smoking cessation
and social interaction (11).
For an adequate intervention, the practice of lifestyle
medicine has structured competencies according to
the American College of Preventive Medicine. These
competencies are: leadership, promoting and
practicing lifestyle behavior; knowledge, in terms of
bene ts and intervention; skills, either social, for
adaptation to change and focused on the patient's
clinical history; therapeutic management, according to
clinical guidelines, with shared medical decision and in
collaboration with the family environment and, nally,
community outreach, by establishing social groups, use
of technology and measurement of processes applied
to lifestyles(12). These competencies require training,
since it has been reported that only 49% of family
physicians feel competent in prescribing a weight
reduction program for obese patients(13). The challenge
will be even greater for patients with chronic
complications, but as we have presented, it is never too
late to do so.

CONCLUSIONS
In the present case, lifestyle medicine has a
fundamental role in the causal factor of the progression
of diabetic nephropathy, which is to achieve optimal
metabolic control. Achieving this goal requires a
multidisciplinary approach and incorporates lifestyle
aspects such as dietary, physical exercise, behavioral
and hypoglycemic medication reduction protocols.
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